DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Klapper JA, Downey SG, Smith FO. et al.
High-dose interleukin-2 for the treatment of metastatic renal cell carcinoma : a retrospective analysis of response and survival in patients treated in the surgery branch at the National Cancer Institute between 1986 and 2006.
Cancer 2008;
113 (02) 293-301
Access:
We do not assume any responsibility for the contents of the web pages of other providers.